Malignant hyperthermia in young patient undergoing a surgical procedure under general anesthesia
Journal: Open Journal of Pain Medicine (Vol.3, No. 1)Publication Date: 2019-05-31
Authors : Estéfano Arias Pastrana Rosa Inés Carrascal Villero Kevin Santiago Jiménez Escudero; Marlon Munera;
Page : 024-026
Keywords : Malignant hyperthermia; Tachycardia; Anesthetics; Dantrolene; Orphan disease;
Abstract
Malignant hyperthermia (MH) is a hypermetabolic disease induced by the administration of anesthetic drugs in patients with genetic susceptibility. Its incidence ranges from 0.02% to 0.0153%. Here, we report the case of an 18-year-old male patient with no previous relevant surgical, medical, or family history of disease, who while undergoing a scheduled orthopedic surgical procedure under general anesthesia for the correction of left congenital talipes equinovarus, presented hyperthermia (41.8°C), muscular stiffness, tachycardia, trismus, increased blood pressure, and increased CO2 levels two hours after the induction of anesthesia. Malignant hyperthermia was suspected and managed following the protocol of the Colombian Anesthesiology and Resuscitation Association (SCARE), and MH diagnosis was confi rmed with response to dantrolene.
Other Latest Articles
- PERFORMANCE OF COMMUNAL SANITATION FACILITY USING COMBINATION OF BIODIGESTER-BIOFILTER AND WASTE BANK FOR DOMESTIC WASTE TREATMENT
- Referred scapula pain from C6 or C7 cervical spinal stenosis
- Methods for saving opioids in the perioperative period via intravenous, via neuraxial and in nervous blocks
- Consensus statement on the management of breakthrough cancer pain
- Outcomes of Extra-Octave Fractures in children
Last modified: 2019-10-03 20:09:34